These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1516508)

  • 1. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V
    Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.
    Dunn FL; Nathan DM; Scavini M; Selam JL; Wingrove TG
    Diabetes Care; 1997 Jan; 20(1):59-63. PubMed ID: 9028695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
    Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C
    Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.
    Olsen CL; Turner DS; Iravani M; Waxman K; Selam JL; Charles MA
    Diabetes Care; 1995 Jan; 18(1):70-6. PubMed ID: 7698051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
    Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
    Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society.
    Broussolle C; Jeandidier N; Hanaire-Broutin H
    Lancet; 1994 Feb; 343(8896):514-5. PubMed ID: 7906761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.
    Saudek CD; Duckworth WC; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA
    JAMA; 1996 Oct 23-30; 276(16):1322-7. PubMed ID: 8861991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Implantable insulin pumps: evaluation after more than 3 years experience].
    Keipes M; Michel G; Pinget M
    Bull Soc Sci Med Grand Duche Luxemb; 1994; 131(1):17-30. PubMed ID: 8050116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients.
    Selam JL; Raccah D; Jean-Didier N; Lozano JL; Waxman K; Charles MA
    Diabetes Care; 1992 Jan; 15(1):53-8. PubMed ID: 1737542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
    Schaepelynck P; Darmon P; Molines L; Jannot-Lamotte MF; Treglia C; Raccah D
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S85-93. PubMed ID: 22208717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs.
    Scavini M; Day PW; Eaton RP
    Artif Organs; 1992 Oct; 16(5):518-22. PubMed ID: 10078304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of severe brittle diabetes with "Infusaid" implantable pumps.
    Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG
    Diabetes Res; 1986 Mar; 3(3):135-7. PubMed ID: 3709039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implantable insulin pump: the first step towards an artificial pancreas].
    Vix M; Mutter D; Jeandidier N; Boivin S; Pinget M; Marescaux J
    Ann Chir; 1994; 48(11):991-7. PubMed ID: 7733607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an integrated sideport for diagnosis and management of decreased flow rates in a programmable implanted insulin delivery system. Implantable Insulin Pump Trial Study Group.
    Scavini M; Reich S; Eaton RP; Charles MA; Dunn FL
    Artif Organs; 1996 Sep; 20(9):991-6. PubMed ID: 8864020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.